Us TOO is a 501(c)3 that empowers the prostate cancer community with educational resources, advocacy initiatives and support services at no charge." title="" class="btn" data-container="body" data-html="true" data-id="42809" data-placement="top" data-toggle="popover" data-trigger="focus" style="color:#b3d4fc" tabindex="0" data-original-title="Us TOO International"> 1,419 8,120
Activities
Entity types
Location
201 N Union St, Alexandria, VA 22314, USA
Alexandria
United States of America
Employees
Scale: 11-50, 51-200
Estimated: 78
Engaged corporates
7Added in Motherbase
5 years, 9 months agoWe're on a mission to ZERO Out prostate cancer. #ZEROProstateCancer
We're on a mission to ZERO OUT prostate cancer.
Events, Cancer Education, Prostate Cancer, Health Equity, Healthcare, Support Programs, Government Relations, advocacy, and Patient Resources
We're working to ZERO Out prostate cancer. #ZEROProstateCancer
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
![]() AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 10 Aug 2023 | | |
![]() Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 16 Apr 2024 | | |
![]() Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 9 Apr 2024 | | |
![]() AbbVie Pharmaceutical, Pharmaceutical Manufacturing | AbbVie Pharmaceutical, Pharmaceutical Manufacturing | Other 26 Aug 2016 10 Aug 2023 | | |
![]() Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 10 Nov 2017 25 Jan 2023 | | |
![]() Intel Corporation IT services, Semiconductors, Semiconductor Manufacturing | Intel Corporation IT services, Semiconductors, Semiconductor Manufacturing | Other 13 Aug 2018 | | |
![]() Bayer Pharmaceutical, Chemistry, Chemical Manufacturing | Bayer Pharmaceutical, Chemistry, Chemical Manufacturing | Other 17 Jun 2017 10 Aug 2023 | | |